ES538473A0 - Un procedimiento para preparar el compuesto n-(4-metoxi-2-metilfenil)-3-(5-nitro-2-furanil)-propenamida. - Google Patents

Un procedimiento para preparar el compuesto n-(4-metoxi-2-metilfenil)-3-(5-nitro-2-furanil)-propenamida.

Info

Publication number
ES538473A0
ES538473A0 ES538473A ES538473A ES538473A0 ES 538473 A0 ES538473 A0 ES 538473A0 ES 538473 A ES538473 A ES 538473A ES 538473 A ES538473 A ES 538473A ES 538473 A0 ES538473 A0 ES 538473A0
Authority
ES
Spain
Prior art keywords
furanil
metoxi
propenamide
methylphenyl
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538473A
Other languages
English (en)
Other versions
ES8601950A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES8601950A1 publication Critical patent/ES8601950A1/es
Publication of ES538473A0 publication Critical patent/ES538473A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
ES538473A 1983-12-13 1984-12-11 Un procedimiento para preparar el compuesto n-(4-metoxi-2-metilfenil)-3-(5-nitro-2-furanil)-propenamida. Granted ES538473A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56111383A 1983-12-13 1983-12-13

Publications (2)

Publication Number Publication Date
ES8601950A1 ES8601950A1 (es) 1985-11-01
ES538473A0 true ES538473A0 (es) 1985-11-01

Family

ID=24240683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538473A Granted ES538473A0 (es) 1983-12-13 1984-12-11 Un procedimiento para preparar el compuesto n-(4-metoxi-2-metilfenil)-3-(5-nitro-2-furanil)-propenamida.

Country Status (6)

Country Link
EP (1) EP0147980A3 (es)
JP (1) JPS60149575A (es)
KR (1) KR850004748A (es)
ES (1) ES538473A0 (es)
ZA (1) ZA849661B (es)
ZW (1) ZW19984A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037751A2 (en) 2002-08-29 2004-05-06 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
WO2007039170A1 (en) * 2005-09-23 2007-04-12 European Molecular Biology Laboratory (Embl) Antagonists of topoisomerase activity and their use in inhibiting pathological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3103517A (en) * 1963-09-10 Z-tfflazolyl
US3726877A (en) * 1970-10-28 1973-04-10 Univ Temple Amine substituted methylene quinuclidone anti-bacterial agents

Also Published As

Publication number Publication date
ES8601950A1 (es) 1985-11-01
KR850004748A (ko) 1985-07-27
ZA849661B (en) 1985-09-25
EP0147980A3 (en) 1985-10-30
EP0147980A2 (en) 1985-07-10
JPS60149575A (ja) 1985-08-07
ZW19984A1 (en) 1985-03-06

Similar Documents

Publication Publication Date Title
ES544297A0 (es) Procedimiento para preparar el compuesto 3-amino-3-deoxi-es-tanina
ES536590A0 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
ES537520A0 (es) Un procedimiento para preparar nuevos peptidos atriales.
ES516866A0 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES534203A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES520364A0 (es) Un procedimiento para preparar compuestos de cefem.
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES531711A0 (es) Procedimiento para preparar un compuesto sulfurado.
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES540091A0 (es) Un procedimiento para preparar el compuesto denominado cl-1565-pt-3
ES538458A0 (es) Un procedimiento para preparar una poliamida.
ES533101A0 (es) Un procedimiento para preparar el compuesto antibacteriano dificidina.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES536864A0 (es) Un procedimiento para preparar derivados de azetidina sustituidos.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES523277A0 (es) Un procedimiento para preparar peptidos.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.